Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium nitroprusside as add-on to antipsychotics in acute schizophrenia exacerbation
2014-002176-83Phase 3Completed
- Sponsor
- CliniRx
- Start
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in schizophrenia comparing Sodium nitroprusside add-on with Placebo add-on (2 arms). Primary endpoint: PANSS total score at end of trial. Started Mar 2015; status: completed.
02
Drugs
sodium nitroprusside
03
Conditions
schizophrenia
Beyond the preview
Go deeper on 2014-002176-83.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-002176-83.